Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Patients with a first episode of unprovoked venous thromboembolism have a high risk of recurrence after discontinuation of anticoagulant therapy. Extending anticoagulation reduces the risk of recurrence but is associated with increased bleeding. Sulodexide, a glycosaminoglycan, exerts antithrombotic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2015-11, Vol.132 (20), p.1891-1897
Hauptverfasser:	Andreozzi, Giuseppe M, Bignamini, Angelo A, Davì, Giovanni, Palareti, Gualtiero, Matuška, Jiří, Holý, Martin, Pawlaczyk-Gabriel, Katarzyna, Džupina, Andrej, Sokurenko, German Y, Didenko, Yury P, Andrei, Laurentia D, Lessiani, Gianfranco, Visonà, Adriana
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anticoagulants - administration & dosage Double-Blind Method Drug Administration Schedule Female Follow-Up Studies Glycosaminoglycans - administration & dosage Humans Male Middle Aged Original Recurrence Secondary Prevention - methods Venous Thromboembolism - diagnosis Venous Thromboembolism - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!